Lena Kristina Bergstrom

Title: Lena Kristina Bergstrom: Innovator in Pharmaceutical Compounds

Introduction

Lena Kristina Bergstrom is a notable inventor based in Lund, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications. With a total of 2 patents, her work has garnered attention in the scientific community.

Latest Patents

Bergstrom's latest patents include innovative compounds that have potential medical uses. One of her inventions involves 2-pyridone compounds, which are designed to inhibit human neutrophil elastase. The invention provides compounds of a specific formula, along with processes and intermediates for their preparation, pharmaceutical compositions containing them, and their therapeutic applications. Another patent focuses on indazolyl sulphonamide derivatives, which are useful as glucocorticoid modulators. These compounds can modulate the glucocorticoid receptor in warm-blooded animals, showcasing their potential in medical therapy.

Career Highlights

Throughout her career, Lena Kristina Bergstrom has worked with prominent companies in the pharmaceutical industry. She has been associated with AstraZeneca AB and Bayer Schering Pharma AG, where she has contributed her expertise in drug development and innovation.

Collaborations

Bergstrom has collaborated with several professionals in her field, including Markus Berger and Jan Dahmen. These collaborations have likely enhanced her research and development efforts, leading to her successful patent applications.

Conclusion

Lena Kristina Bergstrom is a distinguished inventor whose work in pharmaceutical compounds has the potential to impact medical therapies significantly. Her innovative contributions and collaborations highlight her role in advancing the field of pharmaceuticals.